Skip to main content
Premium Trial:

Request an Annual Quote

Visible Genetics Reaffirms Q1 Forecast

NEW YORK, April 8 - Visible Genetics today reaffirmed its first-quarter earnings projections, saying total revenue will come in between $4.2 million and $4.4 million.  


The company reported $3.6 million in revenue over the same period one year ago.


Visible Genetics said it will release on May 30 formal earnings results for the quarter ended March 31.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.